Blueprint Medicines Corporation (BPMC): Price and Financial Metrics
Blueprint Medicines Corporation (BPMC)
Today's Latest Price: $96.91 USD
5.99 (-5.82%)
Updated Jan 26 6:55pm
Add BPMC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BPMC Stock Summary
- Of note is the ratio of Blueprint Medicines Corp's sales and general administrative expense to its total operating expenses; only 16.52% of US stocks have a lower such ratio.
- In terms of twelve month growth in earnings before interest and taxes, Blueprint Medicines Corp is reporting a growth rate of -187.63%; that's higher than merely 10.34% of US stocks.
- As for revenue growth, note that BPMC's revenue has grown 4,965.96% over the past 12 months; that beats the revenue growth of 99.77% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Blueprint Medicines Corp are CLSD, TBIO, LIFE, DRNA, and RCUS.
- BPMC's SEC filings can be seen here. And to visit Blueprint Medicines Corp's official web site, go to www.blueprintmedicines.com.
BPMC Stock Price Chart Interactive Chart >
BPMC Price/Volume Stats
| Current price | $96.91 | 52-week high | $125.61 |
| Prev. close | $102.90 | 52-week low | $43.29 |
| Day low | $96.54 | Volume | 300,100 |
| Day high | $104.00 | Avg. volume | 448,894 |
| 50-day MA | $107.73 | Dividend yield | N/A |
| 200-day MA | $85.74 | Market Cap | 5.40B |
Blueprint Medicines Corporation (BPMC) Company Bio
Blueprint Medicines Corporation makes kinase drugs to treat patients with genomically defined diseases. The company was founded in 2008 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...